Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID-19 using local anaesthesia transperineal biopsy
Open Access
- 1 September 2020
- journal article
- editorial
- Published by Wiley in BJU International
- Vol. 126 (3), 329-332
- https://doi.org/10.1111/bju.15120
Abstract
The COVID‐19 pandemic is impacting all urological cancer services. On March 19th the British Association of Urological Surgeons (BAUS) provided pragmatic guidance for prostate cancer diagnostic services (Table 1 ).(1)This publication has 3 references indexed in Scilit:
- Prolonged presence of SARS-CoV-2 viral RNA in faecal samplesThe Lancet Gastroenterology & Hepatology, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- A Population-Based Cohort Study of the Impact of Infectious Complications Requiring Hospitalization after Prostate Biopsy on Radical Prostatectomy Surgical OutcomesUrology, 2018